Assignee
UNIGEN PHARMACEUTICALS INC
US·16 granted patents·8 pending applications·329 citations·filing 1999–2008
Top patents by PatentIndex Score
24 records- 0196US7514469B2Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agentUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Apr 7, 2009·72 cites·18 claims
- 0293US7972632B2Identification of Free-B-Ring flavonoids as potent COX-2 inhibitorsUNIGEN PHARMACEUTICALS INC·Filed 2007·Granted Jul 5, 2011·20 cites·12 claims
- 0393US7767661B2Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN PHARMACEUTICALS INC·Filed 2008·Granted Aug 3, 2010·15 cites·9 claims
- 0493US7678772B27-hydroxy chromones as potent antioxidantsUNIGEN PHARMACEUTICALS INC·Filed 2005·Granted Mar 16, 2010·24 cites·10 claims
- 0591US7695743B2Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairmentsUNIGEN PHARMACEUTICALS INC·Filed 2007·Granted Apr 13, 2010·17 cites·8 claims
- 0691US7108868B2Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acaciaUNIGEN PHARMACEUTICALS INC·Filed 2002·Granted Sep 19, 2006·37 cites·6 claims
- 0789US7674830B2Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agentUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Mar 9, 2010·22 cites·2 claims
- 0889US7192611B2Identification of Free-B-Ring flavonoids as potent COX-2 inhibitorsUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Mar 20, 2007·32 cites·22 claims
- 0989US6884783B27-Hydroxy chromones as potent antioxidantsUNIGEN PHARMACEUTICALS INC·Filed 2002·Granted Apr 26, 2005·31 cites·12 claims
- 1085US7531521B2Formulation for use in the prevention and treatment of carbohydrate induced diseases and conditionsUNIGEN PHARMACEUTICALS INC·Filed 2004·Granted May 12, 2009·25 cites·10 claims
- 1183US6451357B1Method for purification of aloesinUNIGEN PHARMACEUTICALS INC·Filed 2001·Granted Sep 17, 2002·17 cites·24 claims
- 1277US6683116B1Polycosanols from Ericerus pela waxUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Jan 27, 2004·7 cites·47 claims
- 1368US6984666B2Polycosanols from Ericerus pela waxUNIGEN PHARMACEUTICALS INC·Filed 2004·Granted Jan 10, 2006·2 cites·8 claims
- 1466US7034060B2Polycosanols from Ericerus pela waxUNIGEN PHARMACEUTICALS INC·Filed 2004·Granted Apr 25, 2006·0 cites·5 claims
- 1559US2005239904A1Polycosanols from Ericerus pela waxUNIGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1659US2005267047A1Diarylalkanes as potent inhibitors of binuclear enzymesUNIGEN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 1758US2006251749A1Compositions Of Bakuchiol And Methods Of Making The SameUNIGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1856US6822004B2Polycosanols from ericerus pela waxUNIGEN PHARMACEUTICALS INC·Filed 2003·Granted Nov 23, 2004·0 cites·8 claims
- 1955US2004220119A1Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin careUNIGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2051US6436679B1Process for the preparation of immunodulatory polysaccharides from aloeUNIGEN PHARMACEUTICALS INC·Filed 1999·Granted Aug 20, 2002·8 cites·10 claims
- 2146US2003165588A1Identification of free-B-ring flavonoids as potent COX-2 inhibitorsUNIGEN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
- 2246US2005096281A1Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairmentsUNIGEN PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2344US2006204596A1Formulation of a mixture of Free-B-Ring flavonoids and flavans as a therapeutic agentUNIGEN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2443US2003113797A1Method for generating, screening and dereplicating natural product libraries for the discovery of therapeutic agentsUNIGEN PHARMACEUTICALS INC·Filed 2002·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →